你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能！
| 药品名称 | 剂型 | USP 溶出方法 | 转速（转/min） | 溶出介质 | 容积 | 推荐采样时间 | 更新时间 | 查看详情 |
|---|---|---|---|---|---|---|---|---|
| Encorafenib | Capsule | II (Paddle) with sinker | 100 | Ammonium acetate buffer, pH 4.5 | 900 | 15, 30, 45 and 60 | 2025-03-17 | 查看 |
| Alpelisib | Tablet | II (Paddle) | 75 | Acetate Buffer, pH 4.5 w/0.6% CTAB | 900 | 10, 15, 20, 30 and 45 | 2025-02-24 | 查看 |
| Aprocitentan | Tablet | II (Paddle) | 50 | Phosphate Buffer, pH 6.8 w/0.05% CTAB and 0.5% Tween 20 | 900 | 10, 15, 20, 30 and 45 | 2025-02-24 | 查看 |
| Capivasertib | Tablet | II (Paddle) | 60 | Simulated Gastric Fluid without enzyme, pH 1.2 | 900 | 10, 15, 20, 30 and 45 | 2025-02-24 | 查看 |
| Momelotinib | Tablet | II (Paddle) | 75 | 22 mM Sodium Acetate Buffer, pH 4.5 w/1.3% SDS | 900 | 10, 15, 20, 30 and 45 | 2025-02-24 | 查看 |
| Methyldopa | Tablet | II (Paddle) | 50 | 0.1 N HCl | 900 | 10, 15, 30 and 45 | 2025-01-17 | 查看 |
| Etrasimod Arginine | Tablet | II (Paddle) | 75 | 50 mM Phosphate buffer w/0.2% Tween 20, pH 6.8 | 900 | 5, 15, 20, 30 and 45 | 2024-11-15 | 查看 |
| Valbenazine | Capsule (Sprinkle) | I (Basket) | 50 | 0.1 N HCl | 900 | 5, 15, 20, 30 and 45 | 2024-11-15 | 查看 |
| Acalabrutinib Maleate | Tablet | II (Paddle) | 75 | 5 Mm Phosphate buffer, pH 6.8 | 900 | 5, 10, 15, 20, 30, 45 and 60 | 2024-11-01 | 查看 |
| Allopurinol | Suspension | II (Paddle) | 75 | 0.01 N HCl | 900 | 10, 20, 30, 40, 50 and 60 | 2024-11-01 | 查看 |
| Aripiprazole | Suspension (Extended Release) | IV (Flow through Cell) with closed system | 4 mL/min | Acetate buffer, pH 5.0 | 1000 | 0.5, 0.75, 1, 2, 4, 6, 8, 10, 12, 14, 16 and 18 hours | 2024-11-01 | 查看 |
| Bictegravir Sodium; Emtricitabine; Tenofovir Alafenamide Fumarate | Tablet | II (Paddle) | 75 | 50 mM Citrate buffer, pH 5.5 | 900 | 5, 10, 15, 20, 30, 45 and 60 | 2024-11-01 | 查看 |
| Buspirone Hydrochloride | Capsule | II (Paddle) | 50 | 0.01 N HCl | 500 | 10, 20, 30 and 45 | 2024-11-01 | 查看 |
| Clonazepam | Suspension | Develop a dissolution method | 2024-11-01 | 查看 | ||||
| Estradiol | Vaginal Insert | III (Reciprocating Cylinder) | 30 dips/min | 0.1 N HCl with 0.5% SLS | 250 | 30, 60, 90 and 120 | 2024-11-01 | 查看 |
| Levetiracetam (1 g and 1.5 g) | Tablet (Extended Release) | III (Reciprocating Cylinder) | 15 dips/min | Sodium acetate buffer, pH 4.5 | 900 | 1, 2, 4, 6, 8, 10 and 12 hours | 2024-11-01 | 查看 |
| Memantine HCl | Tablet (Orally Disintegrating) | I (Basket) | 100 | 0.1 N HCl | 900 | 15, 30, 25 and 60 | 2024-11-01 | 查看 |
| Palovarotene | Capsule | II (Paddle) with sinkers | 50 | 5 mM Phosphate buffer, pH 8.0 with 0.5% SLS | 900 | 5, 10, 15, 30, 45 and 60 | 2024-11-01 | 查看 |
| Quizartinib Dihydrochloride | Tablet | II (Paddle) | 50 | 0.1 N HCl | 900 | 15, 20, 30, 45, and 60 | 2024-11-01 | 查看 |
| Ritlecitinib Tosylate | Capsule | Refer to FDA's Dissolution Guidance, 2018 | 2024-11-01 | 查看 |
